Related Experiment Videos
Andrea Chiricozzi1, Antonio Costanzo2, Anna Levi3
1UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Roma - Italy.
Global & Regional Health Technology Assessment
|February 21, 2024
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
The Importance of Achieving High Treatment Targets in Atopic Dermatitis: A Narrative Review.
Dermatology and therapy·2026
Same author
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
Dermatology and therapy·2026
Same author
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).
Acta dermato-venereologica·2026
Same author
Management of patients with hypoparathyroidism: a Delphi consensus analysis.
Journal of endocrinological investigation·2026
Same author
Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings.
Dermatology and therapy·2026
Same author
Lebrikizumab After Multiple Prior Advanced Therapies in Moderate-To-Severe Atopic Dermatitis: A Real-World Case Series.
International journal of dermatology·2026
Same journal
Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.
Global & regional health technology assessment·2026
Same journal
Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.
Global & regional health technology assessment·2026
Same journal
Comments on: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.
Global & regional health technology assessment·2026
Same journal
Author's reply to comments to: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis.
Global & regional health technology assessment·2026
Same journal
Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.
Global & regional health technology assessment·2026
Same journal
Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma.
Global & regional health technology assessment·2026